跳至主要内容
临床试验/NCT02728635
NCT02728635进行中(未招募)不适用

Epigenetic Regulation of Human Adipose Tissue Distribution

AdventHealth Translational Research Institute2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2016年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
27
试验地点
2
主要终点
Epigenetic marks in abdominal vs gluteal subcutaneous adipose tissue and adipocytes

研究概览

简要总结

The purpose of this study is to collect data to help researchers better understand the different ways that women or men store fat (apple shape versus pear shape).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-45 years inclusive;
  • BMI 23-35 kg/m2 inclusive;
  • HbA1C <6.0%;
  • Weight stable (± 3 kg) during the 3 months prior to enrollment;
  • Women must be > 9 months post-partum;
  • Able to provide written, informed consent.

排除标准

  • Postmenopausal women
  • Women with an oophorectomy
  • Fasting plasma glucose > 126 mg/dL, or diagnosis with Type 2 Diabetes (T2DM)
  • Untreated or symptomatic thyroid disease.
  • Aminotransferase or aspartate aminotransferase > 3x upper limit of laboratory reference range, or known diagnosis of liver disease.
  • Creatinine > 2x upper limit of laboratory reference range, or known diagnosis of kidney disease.
  • Uncontrolled hypertension (BP > 140 systolic or > 90 diastolic)
  • New onset (<3 months on a stable regime) use of oral contraceptives or hormone replacement therapy.
  • History of drug or alcohol abuse (> 3 drinks per day) within the last 5 years, or psychiatric disease prohibiting adherence to study protocol. Current drug use may be determine by plasma or urine drug screens.
  • History of cancer within the last 5 years (skin cancers, with the exception of melanoma, may be acceptable).
  • History of organ transplant.
  • Myocardial Infarction within the last 6 months.
  • Current treatment with blood thinners or antiplatelet medications that cannot be safely stopped for biopsy and testing procedures.
  • History of HIV, active Hepatitis B or C or tuberculosis
  • Presence of clinically significant abnormalities on EKG.
  • Current smokers (smoking within the past 3 months).
  • Use of any medications known to influence glucose, fat and/or energy metabolism within the last 3 months (eg. growth hormone therapy, glucocorticoids [steroids], etc.)
  • Other chronic or acute illness that might affect study results / interpretation in the opinion of the clinical
  • Other items related to procedural risk (outlined below) such as bleeding disorder, claustrophobia, etc.
  • Elevated high sensitivity c-reactive protein or known active infection.
  • There are some implants which are MR compatible (safe) but would cause artifacts which could obscure our ability to measure an organ, e.g. full braces may negate the ability to measure brain size.

结局指标

主要结局

Epigenetic marks in abdominal vs gluteal subcutaneous adipose tissue and adipocytes

时间窗: 6 weeks

The preadipocytes obtained from biopsies of Abdominal Fat and Gluteofemoral Fat from patients in the 'pears' woman, 'apple' women and men will be cultured by our standard methods in proliferative medium followed by our standard protocol for differentiation into mature adipocytes. We propose to evaluate samples from 3 individuals from each Group to identify a large number of differentially regulated regions genome wide. All the data obtained in vitro in culture cells will be compared with the data obtained from RNA and chromatin isolated from the whole tissue Abdominal fat and Gluteofemoral fat biopsies

次要结局

未报告次要终点

研究者

发起方
AdventHealth Translational Research Institute
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验